These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 23522341

  • 1. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
    Nishimura R, Sone H, Nakagami T, Tajima N.
    Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
    [Abstract] [Full Text] [Related]

  • 2. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D, Keech A, Hunt D, Marschner I, Simes J, Glasziou P, White H, Barter P, Tonkin A, LIPID Study Investigators.
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [Abstract] [Full Text] [Related]

  • 3. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 4. Risk factors for stroke and lipid-lowering effect of pravastatin on the risk of stroke in Japanese patients with hypercholesterolemia: analysis of data from the MEGA Study, a large randomized controlled trial.
    Uchiyama S, Nakaya N, Mizuno K, Ohashi Y, Tajima N, Kushiro T, Teramoto T, Nakamura H, MEGA Study Group.
    J Neurol Sci; 2009 Sep 15; 284(1-2):72-6. PubMed ID: 19423132
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH, Mortensen ME, Zweig S, Fusco MJ, Medoff JR, Belder R, Pravastatin in Chronic Liver Disease Study Investigators.
    Hepatology; 2007 Nov 15; 46(5):1453-63. PubMed ID: 17668878
    [Abstract] [Full Text] [Related]

  • 6. Statins improve visual field alterations related to hypercholesterolemia.
    Alcalá A, Jansen S, Téllez T, Gómez-Huelgas R, Pérez O, Egido J, Farkouh ME.
    Atherosclerosis; 2010 Apr 15; 209(2):510-4. PubMed ID: 19892351
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 8. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 10; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 9. Effects of pravastatin on exercise electrocardiography test performance and cardiovascular mortality and morbidity in patients with hypercholesterolemia: Lipid Intervention Study in Kyoto.
    Sasaki S, Nakagawa M, Nakata T, Azuma A, Sawada S, Takeda K, Asayama J, Lipid Intrvention Study in Kyoto.
    Circ J; 2002 Jan 10; 66(1):47-52. PubMed ID: 11999665
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM, Jones PH, Adamczyk MA, Cain VA, Bryzinski BS, Blasetto JW, STELLAR Study Group.
    Curr Med Res Opin; 2003 Jan 10; 19(8):689-98. PubMed ID: 14687438
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
    Schuster H, Barter PJ, Stender S, Cheung RC, Bonnet J, Morrell JM, Watkins C, Kallend D, Raza A, Effective Reductions in Cholesterol Using Rosuvastatin Therapy I study group.
    Am Heart J; 2004 Apr 10; 147(4):705-13. PubMed ID: 15077101
    [Abstract] [Full Text] [Related]

  • 13. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
    Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB.
    Arch Intern Med; 1997 Jun 09; 157(11):1186-92. PubMed ID: 9183229
    [Abstract] [Full Text] [Related]

  • 14. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S, Nagao K, Hirayama A.
    Am J Cardiovasc Drugs; 2011 Dec 01; 11(6):411-7. PubMed ID: 22149320
    [Abstract] [Full Text] [Related]

  • 15. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
    Harada N, Kashiwagi A, Nishio Y, Kikkawa R.
    Diabetes Res Clin Pract; 1999 Feb 01; 43(2):111-20. PubMed ID: 10221663
    [Abstract] [Full Text] [Related]

  • 16. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L, Buysschaert M, Hermans MP.
    J Clin Lipidol; 2012 Feb 01; 6(5):434-42. PubMed ID: 23009779
    [Abstract] [Full Text] [Related]

  • 17. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 01; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS, Bissonnette S, Habib R, Boukas S, Ezetrol Add-On Investigators.
    Ann Pharmacother; 2007 Sep 01; 41(9):1345-51. PubMed ID: 17666579
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial.
    Brown WV, Bays HE, Hassman DR, McKenney J, Chitra R, Hutchinson H, Miller E, Rosuvastatin Study Group.
    Am Heart J; 2002 Dec 01; 144(6):1036-43. PubMed ID: 12486428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.